Literature DB >> 6941787

Increased prevalence of DRw3 in the CREST syndrome.

B F Germain, L R Espinoza, L L Bergen, M Vagesh, F B Vasey.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 6941787     DOI: 10.1002/art.1780240615

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

Review 1.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Silica, silicosis, and progressive systemic sclerosis.

Authors:  G K Sluis-Cremer; P A Hessel; E H Nizdo; A R Churchill; E A Zeiss
Journal:  Br J Ind Med       Date:  1985-12

4.  The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).

Authors:  M Kuwana; J Kaburaki; Y Okano; H Inoko; K Tsuji
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).

Authors:  C J Lynch; G Singh; T L Whiteside; G P Rodnan; T A Medsger; B S Rabin
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

6.  Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

Authors:  J D Reveille; E Durban; M J MacLeod-St Clair; R Goldstein; R Moreda; R D Altman; F C Arnett
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Association between HLA-DR antigens and rheumatoid arthritis in Arabs.

Authors:  M A Sattar; M al-Saffar; R T Guindi; T N Sugathan; K Behbehani
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.